Target intelligence / Profile preview

Cathepsin S (CTSS)

Target: CTSS
Molecular classification: Enzyme, Protease, Cysteine protease, Lysosomal enzyme, Peptidase C1 family, Papain-like protease

Overview

Cathepsin S is a lysosomal cysteine protease that plays a critical role in antigen presentation, extracellular matrix degradation, nociception, and autophagy regulation. It is involved in both physiological and pathological processes, making it a drug target for autoimmune, inflammatory, and cardiovascular diseases.

Mechanism of action

Inhibition of cathepsin S enzymatic activity, often through covalent binding to the active site cysteine residue.

Biological functions

Antigen processing/presentationExtracellular matrix degradationNociceptionAutophagy regulationImmune response

Disease associations

AutoimmunityInflammationCardiovascular disease

Safety considerations

Specificity issues due to shared catalytic sites with other cysteine cathepsins.

Beyond the preview

Go deeper on Cathepsin S (CTSS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cathepsin S (CTSS).

Explore the full profile